NO312161B1 - 1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater, fremgangsmåter ved fremstilling derav, anvendelse derav og medikamenterinneholdende disse derivater - Google Patents
1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater, fremgangsmåter ved fremstilling derav, anvendelse derav og medikamenterinneholdende disse derivater Download PDFInfo
- Publication number
- NO312161B1 NO312161B1 NO19985684A NO985684A NO312161B1 NO 312161 B1 NO312161 B1 NO 312161B1 NO 19985684 A NO19985684 A NO 19985684A NO 985684 A NO985684 A NO 985684A NO 312161 B1 NO312161 B1 NO 312161B1
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- spiro
- triaza
- decan
- lower alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 99
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000003814 drug Substances 0.000 title claims description 6
- 229940079593 drug Drugs 0.000 title claims description 6
- JRKPNHLSQGAUDY-UHFFFAOYSA-N 1,3,8-triazaspiro[4.5]decan-4-one Chemical class O=C1NCNC11CCNCC1 JRKPNHLSQGAUDY-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 168
- 239000000203 mixture Substances 0.000 claims description 81
- 239000001257 hydrogen Substances 0.000 claims description 35
- 229910052739 hydrogen Inorganic materials 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- -1 cyanomethyl Chemical group 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 108090000622 Nociceptin Proteins 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- PULGYDLMFSFVBL-SMFNREODSA-N nociceptin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 PULGYDLMFSFVBL-SMFNREODSA-N 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 208000002193 Pain Diseases 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- GHRFRJDKSJJJFQ-UHFFFAOYSA-N 8-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN(C2CC3CCCCC3CC2)CCC11C(=O)NCN1C1=CC=CC=C1 GHRFRJDKSJJJFQ-UHFFFAOYSA-N 0.000 claims description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 208000000044 Amnesia Diseases 0.000 claims description 4
- 208000019901 Anxiety disease Diseases 0.000 claims description 4
- 208000027796 Blood pressure disease Diseases 0.000 claims description 4
- 208000000094 Chronic Pain Diseases 0.000 claims description 4
- 206010010904 Convulsion Diseases 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 claims description 4
- 208000013200 Stress disease Diseases 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 claims description 4
- 208000005298 acute pain Diseases 0.000 claims description 4
- 230000036506 anxiety Effects 0.000 claims description 4
- 230000004872 arterial blood pressure Effects 0.000 claims description 4
- 230000036461 convulsion Effects 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 206010013663 drug dependence Diseases 0.000 claims description 4
- 206010015037 epilepsy Diseases 0.000 claims description 4
- 230000029142 excretion Effects 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 208000014674 injury Diseases 0.000 claims description 4
- 208000030159 metabolic disease Diseases 0.000 claims description 4
- 230000000926 neurological effect Effects 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 235000020824 obesity Nutrition 0.000 claims description 4
- 238000006268 reductive amination reaction Methods 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 208000011117 substance-related disease Diseases 0.000 claims description 4
- 230000008733 trauma Effects 0.000 claims description 4
- 208000026139 Memory disease Diseases 0.000 claims description 3
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 230000006984 memory degeneration Effects 0.000 claims description 3
- 208000023060 memory loss Diseases 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 125000004135 2-norbornyl group Chemical group [H]C1([H])C([H])([H])C2([H])C([H])([H])C1([H])C([H])([H])C2([H])* 0.000 claims description 2
- GWNDTWSMNIBSRN-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN(C2CCCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 GWNDTWSMNIBSRN-UHFFFAOYSA-N 0.000 claims description 2
- IAUDPLBTMXJMKC-UHFFFAOYSA-N 8-cyclononyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN(C2CCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 IAUDPLBTMXJMKC-UHFFFAOYSA-N 0.000 claims description 2
- 230000029936 alkylation Effects 0.000 claims description 2
- 238000005804 alkylation reaction Methods 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 238000005574 benzylation reaction Methods 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 230000006735 deficit Effects 0.000 claims description 2
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 2
- BNRNAKTVFSZAFA-UHFFFAOYSA-N hydrindane Chemical group C1CCCC2CCCC21 BNRNAKTVFSZAFA-UHFFFAOYSA-N 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000004306 triazinyl group Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 102000048266 Nociceptin Human genes 0.000 claims 4
- 206010024264 Lethargy Diseases 0.000 claims 2
- 208000031091 Amnestic disease Diseases 0.000 claims 1
- 206010013496 Disturbance in attention Diseases 0.000 claims 1
- 230000006986 amnesia Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000005508 decahydronaphthalenyl group Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 57
- 239000007787 solid Substances 0.000 description 54
- HTQWGIHCFPWKAS-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CNCCC11C(=O)NCN1C1=CC=CC=C1 HTQWGIHCFPWKAS-UHFFFAOYSA-N 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- PBIUDEUWYGBHDW-UHFFFAOYSA-N 2-chloro-1-pyridin-3-ylethanone;hydrochloride Chemical compound Cl.ClCC(=O)C1=CC=CN=C1 PBIUDEUWYGBHDW-UHFFFAOYSA-N 0.000 description 27
- QFXKFJHPXRIMOV-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 QFXKFJHPXRIMOV-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 20
- 239000011541 reaction mixture Substances 0.000 description 20
- 229910052938 sodium sulfate Inorganic materials 0.000 description 20
- 235000011152 sodium sulphate Nutrition 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000843 powder Substances 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- SXOZDDAFVJANJP-UHFFFAOYSA-N cyclodecanone Chemical compound O=C1CCCCCCCCC1 SXOZDDAFVJANJP-UHFFFAOYSA-N 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 11
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 description 10
- 238000002953 preparative HPLC Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 102400001111 Nociceptin Human genes 0.000 description 9
- 239000000908 ammonium hydroxide Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
- 150000003840 hydrochlorides Chemical class 0.000 description 7
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 7
- RIBPTKSALUVUKH-UHFFFAOYSA-N 8-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CC3CCCCC3CC2)CCC11C(=O)NCN1C1=CC=CC=C1 RIBPTKSALUVUKH-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000000829 suppository Substances 0.000 description 6
- IUAPXXJPOOMKMF-UHFFFAOYSA-N 8-benzyl-1-(3-methylphenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound CC1=CC=CC(N2C3(CCN(CC=4C=CC=CC=4)CC3)C(=O)N=C2)=C1 IUAPXXJPOOMKMF-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- NNFCIYWJLLJEMN-UHFFFAOYSA-N dec-2-en-4-one Chemical compound CCCCCCC(=O)C=CC NNFCIYWJLLJEMN-UHFFFAOYSA-N 0.000 description 5
- 239000007903 gelatin capsule Substances 0.000 description 5
- QUXHCILOWRXCEO-UHFFFAOYSA-M magnesium;butane;chloride Chemical compound [Mg+2].[Cl-].CCC[CH2-] QUXHCILOWRXCEO-UHFFFAOYSA-M 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- SJZKULRDWHPHGG-UHFFFAOYSA-N 1-benzylpiperidin-4-one Chemical compound C1CC(=O)CCN1CC1=CC=CC=C1 SJZKULRDWHPHGG-UHFFFAOYSA-N 0.000 description 4
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 4
- MPVIWMLYFVQZED-UHFFFAOYSA-N 8-benzyl-1-(4-methylphenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound C1=CC(C)=CC=C1N1C2(CCN(CC=3C=CC=CC=3)CC2)C(=O)N=C1 MPVIWMLYFVQZED-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MCXBIZXYNQHVCM-UHFFFAOYSA-N decan-4-one;hydrochloride Chemical compound Cl.CCCCCCC(=O)CCC MCXBIZXYNQHVCM-UHFFFAOYSA-N 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- WKGFCULYSBLJSJ-UHFFFAOYSA-N methyl 2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetate Chemical compound C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CC(=O)OC)CN2C1=CC=CC=C1 WKGFCULYSBLJSJ-UHFFFAOYSA-N 0.000 description 3
- 108010020615 nociceptin receptor Proteins 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- SLHSRCBFPHCSGL-UHFFFAOYSA-N (3-bromo-1-phenylpropyl)benzene Chemical compound C=1C=CC=CC=1C(CCBr)C1=CC=CC=C1 SLHSRCBFPHCSGL-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- XBPPLECAZBTMMK-UHFFFAOYSA-N 2-chloro-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CCl XBPPLECAZBTMMK-UHFFFAOYSA-N 0.000 description 2
- POSWICCRDBKBMH-UHFFFAOYSA-N 3,3,5-trimethylcyclohexan-1-one Chemical compound CC1CC(=O)CC(C)(C)C1 POSWICCRDBKBMH-UHFFFAOYSA-N 0.000 description 2
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 2
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 2
- CJAUDSQXFVZPTO-UHFFFAOYSA-N 3-phenylcyclohexan-1-one Chemical compound C1C(=O)CCCC1C1=CC=CC=C1 CJAUDSQXFVZPTO-UHFFFAOYSA-N 0.000 description 2
- DCSKAMGZSIRJAQ-UHFFFAOYSA-N 4-(2-methylbutan-2-yl)cyclohexan-1-one Chemical compound CCC(C)(C)C1CCC(=O)CC1 DCSKAMGZSIRJAQ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- GNSJWBIUPGPMEP-UHFFFAOYSA-N 8-(2-methylcyclohexyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.CC1CCCCC1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 GNSJWBIUPGPMEP-UHFFFAOYSA-N 0.000 description 2
- JAEHRJNISMZWCV-UHFFFAOYSA-N 8-benzyl-1-(4-chlorophenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound C1=CC(Cl)=CC=C1N1C2(CCN(CC=3C=CC=CC=3)CC2)C(=O)N=C1 JAEHRJNISMZWCV-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- LLGOIFCYNQBHPG-VPLSKCCHSA-N Cl.CCC[C@H]1CC[C@@H](CC1)N1CCC2(CC1)N(CNC2=O)c1ccccc1 Chemical compound Cl.CCC[C@H]1CC[C@@H](CC1)N1CCC2(CC1)N(CNC2=O)c1ccccc1 LLGOIFCYNQBHPG-VPLSKCCHSA-N 0.000 description 2
- XBYDBEWLCFUZNU-BHQIMSFRSA-N Cl.C[C@H]1CC[C@@H](CC1)N1CCC2(CC1)N(CNC2=O)c1ccccc1 Chemical compound Cl.C[C@H]1CC[C@@H](CC1)N1CCC2(CC1)N(CNC2=O)c1ccccc1 XBYDBEWLCFUZNU-BHQIMSFRSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- SXVPOSFURRDKBO-UHFFFAOYSA-N Cyclododecanone Chemical compound O=C1CCCCCCCCCCC1 SXVPOSFURRDKBO-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000004454 Hyperalgesia Diseases 0.000 description 2
- 208000035154 Hyperesthesia Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- NHYXMAKLBXBVEO-UHFFFAOYSA-N bromomethyl acetate Chemical compound CC(=O)OCBr NHYXMAKLBXBVEO-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- YKFKEYKJGVSEIX-UHFFFAOYSA-N cyclohexanone, 4-(1,1-dimethylethyl)- Chemical compound CC(C)(C)C1CCC(=O)CC1 YKFKEYKJGVSEIX-UHFFFAOYSA-N 0.000 description 2
- BAUZLFKYYIVGPM-UHFFFAOYSA-N cyclononanone Chemical compound O=C1CCCCCCCC1 BAUZLFKYYIVGPM-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- IWCVDCOJSPWGRW-UHFFFAOYSA-M magnesium;benzene;chloride Chemical compound [Mg+2].[Cl-].C1=CC=[C-]C=C1 IWCVDCOJSPWGRW-UHFFFAOYSA-M 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- MQWCXKGKQLNYQG-UHFFFAOYSA-N methyl cyclohexan-4-ol Natural products CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- KOHZFTUBIQKPNF-IUCAKERBSA-N (3aS,8aS)-3,3a,4,5,6,7,8,8a-octahydro-2H-azulen-1-one Chemical compound C1CCCC[C@@H]2C(=O)CC[C@@H]21 KOHZFTUBIQKPNF-IUCAKERBSA-N 0.000 description 1
- ATKSQUYIHKMKTG-YUMQZZPRSA-N (3as,7as)-2,3,3a,4,5,6,7,7a-octahydroinden-1-one Chemical compound C1CCC[C@@H]2C(=O)CC[C@@H]21 ATKSQUYIHKMKTG-YUMQZZPRSA-N 0.000 description 1
- UJBOOUHRTQVGRU-ZCFIWIBFSA-N (3r)-3-methylcyclohexan-1-one Chemical compound C[C@@H]1CCCC(=O)C1 UJBOOUHRTQVGRU-ZCFIWIBFSA-N 0.000 description 1
- LGVJRKCQQHOWAU-RKDXNWHRSA-N (4ar,8ar)-3,4,4a,5,6,7,8,8a-octahydro-1h-naphthalen-2-one Chemical compound C1CCC[C@@H]2CC(=O)CC[C@H]21 LGVJRKCQQHOWAU-RKDXNWHRSA-N 0.000 description 1
- LGVJRKCQQHOWAU-BDAKNGLRSA-N (4ar,8as)-3,4,4a,5,6,7,8,8a-octahydro-1h-naphthalen-2-one Chemical compound C1CCC[C@H]2CC(=O)CC[C@H]21 LGVJRKCQQHOWAU-BDAKNGLRSA-N 0.000 description 1
- WKTBCMMWVPTNMK-RISCZKNCSA-N (4as,10ar)-2,4,4a,9,10,10a-hexahydro-1h-phenanthren-3-one Chemical compound C1CC2=CC=CC=C2[C@@H]2[C@H]1CCC(=O)C2 WKTBCMMWVPTNMK-RISCZKNCSA-N 0.000 description 1
- LGVJRKCQQHOWAU-DTWKUNHWSA-N (4as,8ar)-3,4,4a,5,6,7,8,8a-octahydro-1h-naphthalen-2-one Chemical compound C1CCC[C@@H]2CC(=O)CC[C@@H]21 LGVJRKCQQHOWAU-DTWKUNHWSA-N 0.000 description 1
- FFROQSBSJYRALS-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-amine Chemical compound C1CCCC2CC(N)CCC21 FFROQSBSJYRALS-UHFFFAOYSA-N 0.000 description 1
- SQYHQBXVAURWNU-UHFFFAOYSA-N 1,3,4,5-tetrahydrocyclopenta[a]naphthalen-2-one Chemical compound C12=CC=CC=C2CCC2=C1CC(=O)C2 SQYHQBXVAURWNU-UHFFFAOYSA-N 0.000 description 1
- WNRWEBKEQARBKV-UHFFFAOYSA-N 1-(2-chloroethyl)piperidine Chemical compound ClCCN1CCCCC1 WNRWEBKEQARBKV-UHFFFAOYSA-N 0.000 description 1
- RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 1
- SVBJCJUBORTKGJ-UHFFFAOYSA-N 1-(2-methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound COC1=CC=CC=C1N1C2(CCNCC2)C(=O)NC1 SVBJCJUBORTKGJ-UHFFFAOYSA-N 0.000 description 1
- VGROJNHZWNPVJW-UHFFFAOYSA-N 1-(2-methylphenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound CC1=CC=CC=C1N1C2(CCNCC2)C(=O)NC1 VGROJNHZWNPVJW-UHFFFAOYSA-N 0.000 description 1
- FKTLPANFGXXTMF-UHFFFAOYSA-N 1-(4-methylphenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=CC(C)=CC=C1N1C2(CCNCC2)C(=O)NC1 FKTLPANFGXXTMF-UHFFFAOYSA-N 0.000 description 1
- XGASTRVQNVVYIZ-UHFFFAOYSA-N 1-(chloromethyl)-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(CCl)=C1 XGASTRVQNVVYIZ-UHFFFAOYSA-N 0.000 description 1
- VGISFWWEOGVMED-UHFFFAOYSA-N 1-(chloromethyl)-3-methoxybenzene Chemical compound COC1=CC=CC(CCl)=C1 VGISFWWEOGVMED-UHFFFAOYSA-N 0.000 description 1
- XMWGTKZEDLCVIG-UHFFFAOYSA-N 1-(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1 XMWGTKZEDLCVIG-UHFFFAOYSA-N 0.000 description 1
- KCHJBQVSFXXEMX-UHFFFAOYSA-N 1-benzyl-4-(2-methylanilino)piperidine-4-carboxamide Chemical compound CC1=CC=CC=C1NC1(C(N)=O)CCN(CC=2C=CC=CC=2)CC1 KCHJBQVSFXXEMX-UHFFFAOYSA-N 0.000 description 1
- UCIWNGSTPNJNSO-UHFFFAOYSA-N 1-benzyl-4-(3-methylanilino)piperidine-4-carboxamide Chemical compound CC1=CC=CC(NC2(CCN(CC=3C=CC=CC=3)CC2)C(N)=O)=C1 UCIWNGSTPNJNSO-UHFFFAOYSA-N 0.000 description 1
- AEKOWUCMHAZKCM-UHFFFAOYSA-N 1-benzyl-4-(4-chloroanilino)piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(NC=2C=CC(Cl)=CC=2)CCN1CC1=CC=CC=C1 AEKOWUCMHAZKCM-UHFFFAOYSA-N 0.000 description 1
- FTCXTANXUNVWNR-UHFFFAOYSA-N 1-benzyl-4-(4-methylanilino)piperidine-4-carboxamide Chemical compound C1=CC(C)=CC=C1NC1(C(N)=O)CCN(CC=2C=CC=CC=2)CC1 FTCXTANXUNVWNR-UHFFFAOYSA-N 0.000 description 1
- WDSGYHRYGIBXIA-UHFFFAOYSA-N 1-phenyl-8-(3,3,5,5-tetramethylcyclohexyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1C(C)(C)CC(C)(C)CC1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 WDSGYHRYGIBXIA-UHFFFAOYSA-N 0.000 description 1
- JIUGEEAHTMKASG-UHFFFAOYSA-N 1-phenyl-8-(3,3,5-trimethylcyclohexyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1C(C)(C)CC(C)CC1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 JIUGEEAHTMKASG-UHFFFAOYSA-N 0.000 description 1
- YEVWUNLCHKVBKM-UHFFFAOYSA-N 1-phenyl-8-(3-phenylcyclohexyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CC(CCC2)C=2C=CC=CC=2)CCC11C(=O)NCN1C1=CC=CC=C1 YEVWUNLCHKVBKM-UHFFFAOYSA-N 0.000 description 1
- DQZCIEUFDTVNEL-UHFFFAOYSA-N 1-phenyl-8-spiro[5.5]undecan-4-yl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CC3(CCCCC3)CCC2)CCC11C(=O)NCN1C1=CC=CC=C1 DQZCIEUFDTVNEL-UHFFFAOYSA-N 0.000 description 1
- KSMTUIBWLRQUGP-UHFFFAOYSA-N 2-(3-bicyclo[2.2.1]heptanyl)cyclopentan-1-one Chemical compound O=C1CCCC1C1C(C2)CCC2C1 KSMTUIBWLRQUGP-UHFFFAOYSA-N 0.000 description 1
- SIRKPSSXHXSLMR-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate Chemical compound CS(=O)(=O)OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 SIRKPSSXHXSLMR-UHFFFAOYSA-N 0.000 description 1
- OZDBBLPVHISGHA-UHFFFAOYSA-N 2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)-n,n-dimethylacetamide;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CC(=O)N(C)C)CN2C1=CC=CC=C1 OZDBBLPVHISGHA-UHFFFAOYSA-N 0.000 description 1
- XAMLVZXACFHXGT-UHFFFAOYSA-N 2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetamide;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CC(=O)N)CN2C1=CC=CC=C1 XAMLVZXACFHXGT-UHFFFAOYSA-N 0.000 description 1
- WWTRHAWPLXFTMC-UHFFFAOYSA-N 2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetonitrile;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC11C(=O)N(CC#N)CN1C1=CC=CC=C1 WWTRHAWPLXFTMC-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- KKWNLLDAFJTESM-UHFFFAOYSA-N 2-butyl-1-(4-chlorophenyl)-8-cyclodecyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C=1C=C(Cl)C=CC=1N1C(CCCC)NC(=O)C1(CC1)CCN1C1CCCCCCCCC1 KKWNLLDAFJTESM-UHFFFAOYSA-N 0.000 description 1
- ZBRPRNACRCNFHZ-UHFFFAOYSA-N 2-butyl-8-cyclodecyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C=1C=CC=CC=1N1C(CCCC)NC(=O)C1(CC1)CCN1C1CCCCCCCCC1 ZBRPRNACRCNFHZ-UHFFFAOYSA-N 0.000 description 1
- GPIQOFWTZXXOOV-UHFFFAOYSA-N 2-chloro-4,6-dimethoxy-1,3,5-triazine Chemical compound COC1=NC(Cl)=NC(OC)=N1 GPIQOFWTZXXOOV-UHFFFAOYSA-N 0.000 description 1
- XTLPGOXNNLMIEY-UHFFFAOYSA-N 2-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C=1C=CC=CC=1N1C(C)NC(=O)C21CCNCC2 XTLPGOXNNLMIEY-UHFFFAOYSA-N 0.000 description 1
- LFSAPCRASZRSKS-UHFFFAOYSA-N 2-methylcyclohexan-1-one Chemical compound CC1CCCCC1=O LFSAPCRASZRSKS-UHFFFAOYSA-N 0.000 description 1
- OQJMHUOCLRCSED-UHFFFAOYSA-N 3,3,5,5-tetramethylcyclohexan-1-one Chemical compound CC1(C)CC(=O)CC(C)(C)C1 OQJMHUOCLRCSED-UHFFFAOYSA-N 0.000 description 1
- LYMGDGSPFQJRLI-UHFFFAOYSA-N 3,3a,4,5,5a,6,7,8,8a,8b-decahydro-2h-acenaphthylen-1-one Chemical compound C1CCC2C(=O)CC3C2C1CCC3 LYMGDGSPFQJRLI-UHFFFAOYSA-N 0.000 description 1
- JUCWGQDAFCFNEP-UHFFFAOYSA-N 3,3a,4,5,6,7,8,8a-octahydro-1h-azulen-2-one Chemical compound C1CCCCC2CC(=O)CC21 JUCWGQDAFCFNEP-UHFFFAOYSA-N 0.000 description 1
- CNQCWYFDIQSALX-UHFFFAOYSA-N 3-(chloromethyl)pyridine Chemical compound ClCC1=CC=CN=C1 CNQCWYFDIQSALX-UHFFFAOYSA-N 0.000 description 1
- YJZOKOQSQKNYLW-UHFFFAOYSA-N 3-tert-butylcyclohexan-1-one Chemical compound CC(C)(C)C1CCCC(=O)C1 YJZOKOQSQKNYLW-UHFFFAOYSA-N 0.000 description 1
- ZAPMTSHEXFEPSD-UHFFFAOYSA-N 4-(2-chloroethyl)morpholine Chemical compound ClCCN1CCOCC1 ZAPMTSHEXFEPSD-UHFFFAOYSA-N 0.000 description 1
- IPQDZFUZVJKAKZ-UHFFFAOYSA-N 4-(trifluoromethyl)cyclohexan-1-one Chemical compound FC(F)(F)C1CCC(=O)CC1 IPQDZFUZVJKAKZ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- JLYNSPSTPQAEAX-UHFFFAOYSA-N 4-cyclohexylcyclohexan-1-one Chemical compound C1CC(=O)CCC1C1CCCCC1 JLYNSPSTPQAEAX-UHFFFAOYSA-N 0.000 description 1
- OKSDJGWHKXFVME-UHFFFAOYSA-N 4-ethylcyclohexan-1-one Chemical compound CCC1CCC(=O)CC1 OKSDJGWHKXFVME-UHFFFAOYSA-N 0.000 description 1
- VUEQAXHGKCKXFV-UHFFFAOYSA-N 4-phenylbutyl methanesulfonate Chemical compound CS(=O)(=O)OCCCCC1=CC=CC=C1 VUEQAXHGKCKXFV-UHFFFAOYSA-N 0.000 description 1
- YKAYMASDSHFOGI-UHFFFAOYSA-N 4-phenylcyclohexan-1-one Chemical compound C1CC(=O)CCC1C1=CC=CC=C1 YKAYMASDSHFOGI-UHFFFAOYSA-N 0.000 description 1
- FPKISACHVIIMRA-UHFFFAOYSA-N 4-propan-2-ylcyclohexan-1-one Chemical compound CC(C)C1CCC(=O)CC1 FPKISACHVIIMRA-UHFFFAOYSA-N 0.000 description 1
- NQEDLIZOPMNZMC-UHFFFAOYSA-N 4-propylcyclohexan-1-one Chemical compound CCCC1CCC(=O)CC1 NQEDLIZOPMNZMC-UHFFFAOYSA-N 0.000 description 1
- FNOZCEQRXKPZEZ-UHFFFAOYSA-N 5-(chloromethyl)-1,3-oxazolidin-2-one Chemical compound ClCC1CNC(=O)O1 FNOZCEQRXKPZEZ-UHFFFAOYSA-N 0.000 description 1
- JJMJONSGBSLGOQ-UHFFFAOYSA-N 5-[(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)methyl]-1,3-oxazolidin-2-one;hydrochloride Chemical compound Cl.O1C(=O)NCC1CN1C(=O)C2(CCN(CC2)C2CCCCCCCCC2)N(C=2C=CC=CC=2)C1 JJMJONSGBSLGOQ-UHFFFAOYSA-N 0.000 description 1
- YZXZDWVHKDDBGS-UHFFFAOYSA-N 8-(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CC3CCCCCC3C2)CCC11C(=O)NCN1C1=CC=CC=C1 YZXZDWVHKDDBGS-UHFFFAOYSA-N 0.000 description 1
- WZYJDKRLONLGJK-UHFFFAOYSA-N 8-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2C3CCCCC3CCC2)CCC11C(=O)NCN1C1=CC=CC=C1 WZYJDKRLONLGJK-UHFFFAOYSA-N 0.000 description 1
- DZVZUWSJJIGMRV-UHFFFAOYSA-N 8-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN(C2CC3CCCCC3CC2)CCC21C(=O)N(C)CN2C1=CC=CC=C1 DZVZUWSJJIGMRV-UHFFFAOYSA-N 0.000 description 1
- XOPQTVUNWDLVKI-UHFFFAOYSA-N 8-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CC3CCCCC3CC2)CCC21C(=O)N(C)CN2C1=CC=CC=C1 XOPQTVUNWDLVKI-UHFFFAOYSA-N 0.000 description 1
- UHMPASDYKBFBBI-UHFFFAOYSA-N 8-(3-methylcyclohexyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1C(C)CCCC1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 UHMPASDYKBFBBI-UHFFFAOYSA-N 0.000 description 1
- UPJYXNNRCRBZEH-UHFFFAOYSA-N 8-(3-tert-butylcyclohexyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1C(C(C)(C)C)CCCC1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 UPJYXNNRCRBZEH-UHFFFAOYSA-N 0.000 description 1
- RPPSRMMJJRNVNG-UHFFFAOYSA-N 8-(4-methyl-1-propan-2-yl-3-bicyclo[3.1.0]hexanyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1C2(C(C)C)CC2C(C)C1N(CC1)CCC1(C(NC1)=O)N1C1=CC=CC=C1 RPPSRMMJJRNVNG-UHFFFAOYSA-N 0.000 description 1
- UHMPASDYKBFBBI-CLRXKPRGSA-N 8-[(1s,3r)-3-methylcyclohexyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1[C@H](C)CCC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 UHMPASDYKBFBBI-CLRXKPRGSA-N 0.000 description 1
- TZFFPIFLCDYEQC-ULWRCHJDSA-N 8-[(2r,4ar,8ar)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN([C@H]2C[C@H]3CCCC[C@@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 TZFFPIFLCDYEQC-ULWRCHJDSA-N 0.000 description 1
- ZMOMIFCUBOTXIV-XKCSPQBFSA-N 8-[(2r,4ar,8as)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN([C@H]2C[C@@H]3CCCC[C@@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 ZMOMIFCUBOTXIV-XKCSPQBFSA-N 0.000 description 1
- ZMOMIFCUBOTXIV-IEIRFRATSA-N 8-[(2s,4ar,8as)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN([C@@H]2C[C@@H]3CCCC[C@@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 ZMOMIFCUBOTXIV-IEIRFRATSA-N 0.000 description 1
- TZFFPIFLCDYEQC-FEJWXPDQSA-N 8-[(2s,4ar,8as)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN([C@@H]2C[C@@H]3CCCC[C@@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 TZFFPIFLCDYEQC-FEJWXPDQSA-N 0.000 description 1
- ZMOMIFCUBOTXIV-NWSQWKLXSA-N 8-[(2s,4as,8ar)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CN([C@@H]2C[C@H]3CCCC[C@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 ZMOMIFCUBOTXIV-NWSQWKLXSA-N 0.000 description 1
- TZFFPIFLCDYEQC-JURPFWHYSA-N 8-[(2s,4as,8ar)-4a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-naphthalen-2-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN([C@@H]2C[C@H]3CCCC[C@]3(CC2)C)CCC1(C(NC1)=O)N1C1=CC=CC=C1 TZFFPIFLCDYEQC-JURPFWHYSA-N 0.000 description 1
- JHLZVXZWYTUVPA-UHFFFAOYSA-N 8-[2-(3-bicyclo[2.2.1]heptanyl)cyclopentyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2C(CCC2)C2C3CCC(C3)C2)CCC11C(=O)NCN1C1=CC=CC=C1 JHLZVXZWYTUVPA-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- LGSKWMMXNUSNIW-UHFFFAOYSA-N 8-benzyl-1-(2-methylphenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound CC1=CC=CC=C1N1C2(CCN(CC=3C=CC=CC=3)CC2)C(=O)N=C1 LGSKWMMXNUSNIW-UHFFFAOYSA-N 0.000 description 1
- SWSPODLAWAERSY-UHFFFAOYSA-N 8-benzyl-1-phenyl-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound C1CN(CC=2C=CC=CC=2)CCC11C(=O)N=CN1C1=CC=CC=C1 SWSPODLAWAERSY-UHFFFAOYSA-N 0.000 description 1
- HAWAHFJVIRVRSU-UHFFFAOYSA-N 8-cyclodecyl-1-(2-methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.COC1=CC=CC=C1N1C2(CCN(CC2)C2CCCCCCCCC2)C(=O)NC1 HAWAHFJVIRVRSU-UHFFFAOYSA-N 0.000 description 1
- GUTURKYFMCPQLN-UHFFFAOYSA-N 8-cyclodecyl-1-(2-methylphenyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.CC1=CC=CC=C1N1C2(CCN(CC2)C2CCCCCCCCC2)C(=O)NC1 GUTURKYFMCPQLN-UHFFFAOYSA-N 0.000 description 1
- MHYHNMTZECNSQL-UHFFFAOYSA-N 8-cyclodecyl-1-(4-methylphenyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1N1C2(CCN(CC2)C2CCCCCCCCC2)C(=O)NC1 MHYHNMTZECNSQL-UHFFFAOYSA-N 0.000 description 1
- VLJDOIATSHJKQR-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(2-piperidin-1-ylethyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCN1CCCCC1 VLJDOIATSHJKQR-UHFFFAOYSA-N 0.000 description 1
- ALXZYUOACPGKLU-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(2-pyrrolidin-1-ylethyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCN1CCCC1 ALXZYUOACPGKLU-UHFFFAOYSA-N 0.000 description 1
- UPIURZHIBROUDZ-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(3-phenylpropyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCCC1=CC=CC=C1 UPIURZHIBROUDZ-UHFFFAOYSA-N 0.000 description 1
- WGQSGTRFAKCDFM-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(3-piperidin-1-ylpropyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCCN1CCCCC1 WGQSGTRFAKCDFM-UHFFFAOYSA-N 0.000 description 1
- JIIAECCQMVVJOK-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCCCC1=CC=CC=C1 JIIAECCQMVVJOK-UHFFFAOYSA-N 0.000 description 1
- NVLBCUZICCKTLM-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-(pyridin-3-ylmethyl)-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CC1=CC=CN=C1 NVLBCUZICCKTLM-UHFFFAOYSA-N 0.000 description 1
- GLEGCXPANDPTSG-UHFFFAOYSA-N 8-cyclodecyl-1-phenyl-3-[[3-(trifluoromethyl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC=CC(CN2C(C3(CCN(CC3)C3CCCCCCCCC3)N(C=3C=CC=CC=3)C2)=O)=C1 GLEGCXPANDPTSG-UHFFFAOYSA-N 0.000 description 1
- LXGPTDSVTRUKDE-UHFFFAOYSA-N 8-cyclodecyl-3-(2-hydroxyethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CCO)CN2C1=CC=CC=C1 LXGPTDSVTRUKDE-UHFFFAOYSA-N 0.000 description 1
- FVRNUWSQCDBGLQ-UHFFFAOYSA-N 8-cyclodecyl-3-(2-morpholin-4-ylethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCN1CCOCC1 FVRNUWSQCDBGLQ-UHFFFAOYSA-N 0.000 description 1
- OCLJYWCRWQCPJD-UHFFFAOYSA-N 8-cyclodecyl-3-(3,3-diphenylpropyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1N(C=2C=CC=CC=2)C2(CCN(CC2)C2CCCCCCCCC2)C(=O)N1CCC(C=1C=CC=CC=1)C1=CC=CC=C1 OCLJYWCRWQCPJD-UHFFFAOYSA-N 0.000 description 1
- DJZORHYJRNHCJT-UHFFFAOYSA-N 8-cyclodecyl-3-(4,6-dimethoxy-1,3,5-triazin-2-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.COC1=NC(OC)=NC(N2C(C3(CCN(CC3)C3CCCCCCCCC3)N(C=3C=CC=CC=3)C2)=O)=N1 DJZORHYJRNHCJT-UHFFFAOYSA-N 0.000 description 1
- XKDKGOAHVGKQQC-UHFFFAOYSA-N 8-cyclodecyl-3-[(3-methoxyphenyl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.COC1=CC=CC(CN2C(C3(CCN(CC3)C3CCCCCCCCC3)N(C=3C=CC=CC=3)C2)=O)=C1 XKDKGOAHVGKQQC-UHFFFAOYSA-N 0.000 description 1
- XUHCSBQOEWXDIB-UHFFFAOYSA-N 8-cyclodecyl-3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.CC=1OC(C=2C=CC=CC=2)=NC=1CCN(C(C12CCN(CC2)C2CCCCCCCCC2)=O)CN1C1=CC=CC=C1 XUHCSBQOEWXDIB-UHFFFAOYSA-N 0.000 description 1
- MLYCOPSSASWBGZ-UHFFFAOYSA-N 8-cyclodecyl-3-cyclopentyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC11C(=O)N(C2CCCC2)CN1C1=CC=CC=C1 MLYCOPSSASWBGZ-UHFFFAOYSA-N 0.000 description 1
- YZYFWRSKPSSWAP-UHFFFAOYSA-N 8-cyclodecyl-3-ethyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CC)CN2C1=CC=CC=C1 YZYFWRSKPSSWAP-UHFFFAOYSA-N 0.000 description 1
- YAQJRTYSYHMLOW-UHFFFAOYSA-N 8-cyclodecyl-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(C)CN2C1=CC=CC=C1 YAQJRTYSYHMLOW-UHFFFAOYSA-N 0.000 description 1
- SASRDFFALVVNAE-UHFFFAOYSA-N 8-cyclododecyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 SASRDFFALVVNAE-UHFFFAOYSA-N 0.000 description 1
- UNCRMIUIZDTUHL-UHFFFAOYSA-N 8-cycloheptyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 UNCRMIUIZDTUHL-UHFFFAOYSA-N 0.000 description 1
- PFUFNMACFDLTQY-UHFFFAOYSA-N 8-cyclohexyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 PFUFNMACFDLTQY-UHFFFAOYSA-N 0.000 description 1
- FIXTWNAQAPKOJV-UHFFFAOYSA-N 8-cyclononyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 FIXTWNAQAPKOJV-UHFFFAOYSA-N 0.000 description 1
- LRBBMQDYLKANFO-UHFFFAOYSA-N 8-cyclooctyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 LRBBMQDYLKANFO-UHFFFAOYSA-N 0.000 description 1
- XNPURTCVFSYETC-UHFFFAOYSA-N 8-cycloundecyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCCC2)CCC11C(=O)NCN1C1=CC=CC=C1 XNPURTCVFSYETC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 101150078806 BCAT2 gene Proteins 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 102100026413 Branched-chain-amino-acid aminotransferase, mitochondrial Human genes 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XYLBVVXZZFVGLC-VPLSKCCHSA-N Cl.C(C)(C)(C)[C@@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=CC=C2)=O)CC1 Chemical compound Cl.C(C)(C)(C)[C@@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=CC=C2)=O)CC1 XYLBVVXZZFVGLC-VPLSKCCHSA-N 0.000 description 1
- FMOQORUPVBAXMR-UHFFFAOYSA-N Cl.C1(CCCCCCCC1N1CCC2(C(NCN2C2=CC=CC=C2)=O)CC1)C1CCCCCCCC1 Chemical compound Cl.C1(CCCCCCCC1N1CCC2(C(NCN2C2=CC=CC=C2)=O)CC1)C1CCCCCCCC1 FMOQORUPVBAXMR-UHFFFAOYSA-N 0.000 description 1
- PYJOGUZHFCMKRE-VPLSKCCHSA-N Cl.C1C[C@@H](C(C)C)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 Chemical compound Cl.C1C[C@@H](C(C)C)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 PYJOGUZHFCMKRE-VPLSKCCHSA-N 0.000 description 1
- NJWTYZLIMUVLRX-NRZPPVGBSA-N Cl.C1C[C@@H](C(F)(F)F)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 Chemical compound Cl.C1C[C@@H](C(F)(F)F)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 NJWTYZLIMUVLRX-NRZPPVGBSA-N 0.000 description 1
- ZRLFUOSBCICFAP-YHSIFKNPSA-N Cl.C1C[C@@H](CC)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 Chemical compound Cl.C1C[C@@H](CC)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 ZRLFUOSBCICFAP-YHSIFKNPSA-N 0.000 description 1
- WNDWAAWQBJNFBI-AELULUIVSA-N Cl.C[C@@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=C(C=C2)C)=O)CC1 Chemical compound Cl.C[C@@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=C(C=C2)C)=O)CC1 WNDWAAWQBJNFBI-AELULUIVSA-N 0.000 description 1
- WNDWAAWQBJNFBI-YMPPOUHLSA-N Cl.C[C@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=C(C=C2)C)=O)CC1 Chemical compound Cl.C[C@H]1CC[C@H](CC1)N1CCC2(C(NCN2C2=CC=C(C=C2)C)=O)CC1 WNDWAAWQBJNFBI-YMPPOUHLSA-N 0.000 description 1
- KFUQBLGNEDGNRL-UHFFFAOYSA-N Cl.O=C1CCCC11CCCCC1 Chemical compound Cl.O=C1CCCC11CCCCC1 KFUQBLGNEDGNRL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102400000242 Dynorphin A(1-17) Human genes 0.000 description 1
- 108010065372 Dynorphins Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 230000001270 agonistic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- BRTFVKHPEHKBQF-UHFFFAOYSA-N bromocyclopentane Chemical compound BrC1CCCC1 BRTFVKHPEHKBQF-UHFFFAOYSA-N 0.000 description 1
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- NHTGUVBHHDMIOT-WGSAOQKQSA-N chembl353608 Chemical compound C1C[C@@H](CCC)CC[C@@H]1N1CCC2(C(NCN2C=2C=CC=CC=2)=O)CC1 NHTGUVBHHDMIOT-WGSAOQKQSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- IIRFCWANHMSDCG-UHFFFAOYSA-N cyclooctanone Chemical compound O=C1CCCCCCC1 IIRFCWANHMSDCG-UHFFFAOYSA-N 0.000 description 1
- UPOSSYJVWXLPTA-UHFFFAOYSA-N cycloundecanone Chemical compound O=C1CCCCCCCCCC1 UPOSSYJVWXLPTA-UHFFFAOYSA-N 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- MKJDUHZPLQYUCB-UHFFFAOYSA-N decan-4-one Chemical compound CCCCCCC(=O)CCC MKJDUHZPLQYUCB-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- JMNJYGMAUMANNW-FIXZTSJVSA-N dynorphin a Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 JMNJYGMAUMANNW-FIXZTSJVSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000006274 endogenous ligand Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OZIDXCYIYGSQRU-UHFFFAOYSA-N ethyl 5-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)pentanoate;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CCCCC(=O)OCC)CN2C1=CC=CC=C1 OZIDXCYIYGSQRU-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- LVKCSZQWLOVUGB-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].C[CH-]C LVKCSZQWLOVUGB-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- ZFRIZGKGVHDLOM-UHFFFAOYSA-N methyl 2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetate;hydrochloride Chemical compound Cl.C1CN(C2CCCCCCCCC2)CCC21C(=O)N(CC(=O)OC)CN2C1=CC=CC=C1 ZFRIZGKGVHDLOM-UHFFFAOYSA-N 0.000 description 1
- NNIFSEIFKGLPGS-UHFFFAOYSA-N n-benzyl-2-(8-cyclodecyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetamide;hydrochloride Chemical compound Cl.C=1C=CC=CC=1CNC(=O)CN(C(C12CCN(CC2)C2CCCCCCCCC2)=O)CN1C1=CC=CC=C1 NNIFSEIFKGLPGS-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003040 nociceptive effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002400 pro-nociceptive effect Effects 0.000 description 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- FEYUTRZPSFLEST-UHFFFAOYSA-N spiro[5.5]undecan-4-one Chemical compound C1C(=O)CCCC11CCCCC1 FEYUTRZPSFLEST-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Color Printing (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97121427 | 1997-12-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO985684D0 NO985684D0 (no) | 1998-12-04 |
| NO985684L NO985684L (no) | 1999-06-07 |
| NO312161B1 true NO312161B1 (no) | 2002-04-02 |
Family
ID=8227753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19985684A NO312161B1 (no) | 1997-12-05 | 1998-12-04 | 1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater, fremgangsmåter ved fremstilling derav, anvendelse derav og medikamenterinneholdende disse derivater |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6043366A (cs) |
| JP (1) | JP3366868B2 (cs) |
| KR (1) | KR19990062800A (cs) |
| CN (1) | CN1118467C (cs) |
| AR (1) | AR016428A1 (cs) |
| AT (1) | ATE212635T1 (cs) |
| AU (1) | AU744338B2 (cs) |
| BR (1) | BR9805297B1 (cs) |
| CA (1) | CA2255171C (cs) |
| CO (1) | CO4990965A1 (cs) |
| CZ (1) | CZ399698A3 (cs) |
| DE (1) | DE69803653T2 (cs) |
| DK (1) | DK0921125T3 (cs) |
| ES (1) | ES2170446T3 (cs) |
| HR (1) | HRP980613A2 (cs) |
| HU (1) | HUP9802807A3 (cs) |
| ID (1) | ID21413A (cs) |
| IL (1) | IL127399A0 (cs) |
| MA (1) | MA26573A1 (cs) |
| NO (1) | NO312161B1 (cs) |
| NZ (1) | NZ333159A (cs) |
| PE (1) | PE135299A1 (cs) |
| PL (1) | PL330062A1 (cs) |
| PT (1) | PT921125E (cs) |
| SG (1) | SG71173A1 (cs) |
| TR (1) | TR199802520A2 (cs) |
| TW (1) | TW408123B (cs) |
| YU (1) | YU55198A (cs) |
| ZA (1) | ZA9811128B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2237047T3 (es) * | 1998-10-23 | 2005-07-16 | Pfizer Inc. | Compuestos de 1,3,8-triazaespiro(4,5)decanona como agonistas del receptor orl1. |
| US6686370B2 (en) * | 1999-12-06 | 2004-02-03 | Euro-Celtique S.A. | Triazospiro compounds having nociceptin receptor affinity |
| US7192964B2 (en) * | 2001-07-23 | 2007-03-20 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiropiperidine derivatives |
| DK1491212T3 (da) * | 2002-03-29 | 2012-10-29 | Mitsubishi Tanabe Pharma Corp | Middel til behandling af søvnforstyrrelser |
| PL377047A1 (pl) * | 2002-09-09 | 2006-01-23 | Janssen Pharmaceutica, N.V. | Hydroksyalkilopodstawione pochodne 1,3,8-triazaspiro [4,5]-dekan-4-onu przydatne w leczeniu zaburzeń, w których pośredniczy receptor ORL-1 |
| WO2004058727A1 (en) * | 2002-12-20 | 2004-07-15 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| ZA200510329B (en) * | 2003-05-23 | 2007-04-25 | Zealand Pharma As | Triaza-spiro compounds as nociceptin analogues and uses thereof |
| MXPA06004305A (es) * | 2003-10-23 | 2006-06-05 | Hoffmann La Roche | Derivados de triaza-espiropiperidina para uso como inhibidores del transformador de glicina 1 en tratamiento de enfermedades neurologicas y neuropsiquiatricas. |
| US20060178390A1 (en) * | 2004-08-02 | 2006-08-10 | Alfonzo Jordan | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| CN101146801A (zh) * | 2005-03-22 | 2008-03-19 | 霍夫曼-拉罗奇有限公司 | 新型的dpp-iv抑制剂的盐和多晶型物 |
| US20070299072A1 (en) * | 2006-06-20 | 2007-12-27 | Wyeth | Kv1.5 potassium channel inhibitors |
| KR20090083954A (ko) * | 2006-11-28 | 2009-08-04 | 얀센 파마슈티카 엔.브이. | 3-(3-아미노-2-(ｒ)-하이드록시프로필)-1-(4-플루오로페닐)-8-(8-메틸나프탈렌-1-일메틸)-1,3,8-트리아자-스피로[4.5]데칸-4-온의 염 |
| WO2008105497A1 (ja) | 2007-03-01 | 2008-09-04 | Mitsubishi Tanabe Pharma Corporation | ベンゾイミダゾール化合物およびその医薬用途 |
| WO2008124209A1 (en) * | 2007-04-09 | 2008-10-16 | Janssen Pharmaceutica, N.V. | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
| PA8801401A1 (es) * | 2007-10-25 | 2009-05-15 | Janssen Pharmaceutica Nv | Arilindenopirimidinas y su uso como adenosina a2a |
| TW201016675A (en) * | 2008-09-16 | 2010-05-01 | Mitsubishi Tanabe Pharma Corp | Crystalline benzoimidazole compound and salt thereof |
| US20100076003A1 (en) * | 2008-09-19 | 2010-03-25 | Kathleen Battista | 5-oxazolidin-2-one substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful as orl-1 receptor modulators |
| WO2010037081A1 (en) * | 2008-09-29 | 2010-04-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific spiro-piperidine compounds |
| EP2443124B1 (en) | 2009-06-16 | 2014-01-22 | Merck Sharp & Dohme Corp. | Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones |
| EP3317279B1 (en) * | 2015-07-03 | 2021-01-27 | H. Hoffnabb-La Roche Ag | Triaza-spirodecanones as ddr1 inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155670A (en) * | 1962-06-22 | 1964-11-03 | Res Lab Dr C Janssen N V | 1-oxo-2, 4, 8, triaza-spiro (4, 5) decanes |
| US3155669A (en) * | 1962-06-22 | 1964-11-03 | Res Lab Dr C Janssen N V | 2, 4, 8-triaza-spiro (4, 5) dec-2-enes |
| US3161644A (en) * | 1962-06-22 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-benzyl-4-substituted piperidines |
| US3238216A (en) * | 1963-06-20 | 1966-03-01 | Res Lab Dr C Janssen N V | Substituted 1, 3, 8-triaza-spiro (4, 5) decanes |
| GB1486546A (en) * | 1975-02-28 | 1977-09-21 | Yoshitomo Pharma Ind Ltd | 4,4-diphenyl-cyclohexylpiperidine compounds and analogues thereof |
| JPS5212171A (en) * | 1975-07-17 | 1977-01-29 | Yoshitomi Pharmaceut Ind Ltd | Process for preparation of cyclohexane derivatives |
| JPS51100084A (cs) * | 1975-02-28 | 1976-09-03 | Yoshitomi Pharmaceutical | |
| JPS5934713B2 (ja) * | 1976-01-05 | 1984-08-24 | ウェルファイド株式会社 | 脂環式誘導体 |
| US4076821A (en) * | 1976-02-27 | 1978-02-28 | Yoshitomi Pharmaceutical Industries, Ltd. | 4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof |
| GR73633B (cs) * | 1980-03-10 | 1984-03-26 | Janssen Pharmaceutica Nv | |
| MA19091A1 (fr) * | 1980-03-10 | 1981-10-01 | Janssen Pharmaceutica Nv | Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine . |
| US4329353A (en) * | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
| DE3485094D1 (de) * | 1983-01-25 | 1991-10-31 | Ciba Geigy Ag | Neue peptidderivate. |
| JPS6012357B2 (ja) * | 1984-01-23 | 1985-04-01 | 吉富製薬株式会社 | 脂環式誘導体 |
| CA2226058C (en) * | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
-
1998
- 1998-11-27 AT AT98122511T patent/ATE212635T1/de active
- 1998-11-27 DK DK98122511T patent/DK0921125T3/da active
- 1998-11-27 PT PT98122511T patent/PT921125E/pt unknown
- 1998-11-27 ES ES98122511T patent/ES2170446T3/es not_active Expired - Lifetime
- 1998-11-27 DE DE69803653T patent/DE69803653T2/de not_active Expired - Lifetime
- 1998-12-03 AR ARP980106141A patent/AR016428A1/es active IP Right Grant
- 1998-12-03 PE PE1998001176A patent/PE135299A1/es not_active Application Discontinuation
- 1998-12-03 CA CA002255171A patent/CA2255171C/en not_active Expired - Fee Related
- 1998-12-03 PL PL98330062A patent/PL330062A1/xx unknown
- 1998-12-03 SG SG1998005141A patent/SG71173A1/en unknown
- 1998-12-03 NZ NZ333159A patent/NZ333159A/en unknown
- 1998-12-03 YU YU55198A patent/YU55198A/sh unknown
- 1998-12-03 ID IDP981576A patent/ID21413A/id unknown
- 1998-12-03 US US09/204,184 patent/US6043366A/en not_active Expired - Fee Related
- 1998-12-04 IL IL12739998A patent/IL127399A0/xx unknown
- 1998-12-04 BR BRPI9805297-7A patent/BR9805297B1/pt not_active IP Right Cessation
- 1998-12-04 CZ CZ983996A patent/CZ399698A3/cs unknown
- 1998-12-04 AU AU96087/98A patent/AU744338B2/en not_active Ceased
- 1998-12-04 ZA ZA9811128A patent/ZA9811128B/xx unknown
- 1998-12-04 MA MA25369A patent/MA26573A1/fr unknown
- 1998-12-04 NO NO19985684A patent/NO312161B1/no not_active IP Right Cessation
- 1998-12-04 HU HU9802807A patent/HUP9802807A3/hu unknown
- 1998-12-04 TR TR1998/02520A patent/TR199802520A2/xx unknown
- 1998-12-04 CN CN98122759A patent/CN1118467C/zh not_active Expired - Fee Related
- 1998-12-04 TW TW087120132A patent/TW408123B/zh not_active IP Right Cessation
- 1998-12-04 JP JP34527898A patent/JP3366868B2/ja not_active Expired - Fee Related
- 1998-12-04 CO CO98072457A patent/CO4990965A1/es unknown
- 1998-12-04 KR KR1019980053080A patent/KR19990062800A/ko not_active Ceased
- 1998-12-04 HR HR97121427.5A patent/HRP980613A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0921125B1 (en) | 1,3,8-Triazaspiro[4,5]decan-4-on derivatives | |
| NO312161B1 (no) | 1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater, fremgangsmåter ved fremstilling derav, anvendelse derav og medikamenterinneholdende disse derivater | |
| AU730147B2 (en) | 8-substituted-1,3,8-triaza-spiro(4.5)decan-4-on derivatives | |
| TW201414735A (zh) | 三環喹啉及喹噁啉衍生物 | |
| AU743983B2 (en) | Diaza-spiro (3,5)nonane derivatives | |
| EP0963985B1 (en) | Di-or triaza-spiro(4,5)decane derivatives | |
| CA2274204C (en) | Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] | |
| MXPA98010263A (en) | Derivatives of 1,3,8-triaza-espiro [4,5] decan-4- | |
| NZ561905A (en) | Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2003 |